About Cellex
Cellex is a Healthcare company based in Koln (Germany). Cellex is established as a full-service CDMO for cell and gene therapy. It operates on a Professional Services and Managed Services model. Cellex offers products and services including Manufacturing of ATMPs/CGT Products, Cell Collection, Consultancy & Audits, and Supply Chain & Logistics. Its focus areas include Biotechnology and Cell and Gene Therapy.
Company details
Cellex is recognized as a leading contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. Services are provided to pharmaceutical companies, biotech firms, and academic institutions, covering manufacturing of advanced therapy medicinal products (ATMPs) and cell and gene therapy (CGT) products for clinical trials and commercial applications. Expertise is offered in autologous and allogeneic cell collection, process development, validation, and supply chain logistics. Consulting and GMP audits are conducted to ensure compliance and support from preclinical stages to commercialization. Solutions are tailored to meet the needs of partners in the biotechnology and healthcare sectors, leveraging over a decade of experience to deliver innovative therapies.
- Latest Funding Round$2M (USD), Grant
Mar 2010
- Investors
Products & Services of Cellex
Cellex offers a comprehensive portfolio of products and services, including Manufacturing of ATMPs/CGT Products, Cell Collection, Consultancy & Audits, and Supply Chain & Logistics.
Cellular products are manufactured for clinical and commercial use.
Starting materials are collected for cell therapy products.
Consulting and audits are provided for GMP compliance.
Logistics solutions are offered for cell therapy materials.
Funding Insights of Cellex
- Total Rounds 1
- Last Round Grant — $2M
- First Round $2M
(Mar 2010)
- Investors Count 1
All 1 funding rounds of Cellex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2010 | $2M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Cellex
Cellex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Cellex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellex
13 people are tracked at Cellex (6 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Nataliya Gerdt | Senior Medical Director | Leadership |
Gerhard Ehninger | CEO | Leadership |
Carla Kreissig | Medical Director & CEO | Leadership |
Ulf Wittstock | Administration, VP | Leadership |
Dirk Winnemöller | Vice President Commercial | Leadership |
Armin Ehninger | Chief Scientific & Strategic Officer | Leadership |
Doris Händeler-Haviar | Medical Specialist, Blood Banking & Anesthesiology | Team |
Maria-Luiza Polici | Physician | Team |
Lucas Bohn | Physican | Team |
Angelika Koch | Nursing Staff | Team |
Dr Jennifer Frosch | Quality Assurance Officer | Team |
Alexandra Klette | Leiterin Der Personalabteilung | Team |
Milad Alimohammadi | Qualified Person | Team |
Complete people profiles for Cellex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellex
Complete news archive for Cellex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellex
Cellex is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Cellex is recognized as a leading contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. Services are provided to pharmaceutical companies, biotech firms, and academic institutions, covering manufacturing of advanced therapy medicinal products (ATMPs) and cell and gene therapy (CGT) products for clinical trials and commercial applications. Expertise is offered in autologous and allogeneic cell collection, process development, validation, and supply chain logistics. Consulting and GMP audits are conducted to ensure compliance and support from preclinical stages to commercialization. Solutions are tailored to meet the needs of partners in the biotechnology and healthcare sectors, leveraging over a decade of experience to deliver innovative therapies.
Cellex offers Manufacturing of ATMPs/CGT Products, Cell Collection, Consultancy & Audits, and Supply Chain & Logistics.
Cellex has 1 investor. Key investors include HHS.